{
  "pmcid": "4092722",
  "sha256": "6ab1c17ad058fca4912c6cab6188a9947397faa3734f19460267a9feffbef59f",
  "timestamp_utc": "2025-11-09T22:41:06.694020+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.247235294117651,
    "reading_ease": 21.040823529411767,
    "word_count": 200
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Ventricular Performance Parameters in Coronary Artery Bypass Grafting"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Fourteen patients with preoperative EF >35% and no contraindication to transoesophageal echocardiography (TEE) were included."
      },
      "Participants": {
        "score": 2,
        "evidence": "Fourteen patients with preoperative EF >35% and no contraindication to transoesophageal echocardiography (TEE) were included. The study was conducted during elective CABG."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Eight patients received dobutamine 2.5 μg/kg/min before cardiopulmonary bypass (CPB) to assess ventricular reserve."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates ventricular performance using preload adjusted peak power (PAPP), cardiac cycle efficiency (CCE), and ejection fraction (EF) in patients undergoing coronary artery bypass grafting (CABG)."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "PAPP was calculated using peak systolic aortic pressure and peak aortic blood flow velocity."
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Fourteen patients with preoperative EF >35% and no contraindication to transoesophageal echocardiography (TEE) were included."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Dobutamine infusion improved PAPP values (2.4 ± 0.9 vs 3.2 ± 0.8) in all eight patients, though statistical analysis was limited by sample size."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not provided."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not disclosed."
      }
    },
    "total_score": 12,
    "max_score": 25
  }
}